Nektar Therapeutics

Nektar Therapeutics

Clinical-stage biopharmaceutical company developing a pipeline of drug candidates. Learn more

Launch date
Employees
Market cap
€209m
Enterprise valuation
€65m (Public information from Sep 2024)
San Carlos California (HQ)
Authorizing premium user...